This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
Rejenevie™ Therapeutics Announces Start of Phase II Immune Restoration Treatment Clinical Trial
Rejenevie™ Therapeutics announced the commencement of the company’s Phase II clinical trial to study the safety and effectiveness of its proprietary AR-100 immune restoration therapy to boost the function of